Network (NCCN) guidelines have expanded to recommend genetic testing for metastatic, intraductal/cribriform histology, and/or highor very-high risk group prostate cancer (NCCN: Breast, Ovarian, and Pancreatic, 2022), leading to a higher volume of patients being referred for hereditary prostate cancer genetic testing. Hereditary prostate cancers are caused by pathogenic variants (PVs) in cancerassociated genes that increase an individual's lifetime risk of cancer.Most known PVs associated with hereditary prostate cancer follow an autosomal dominant pattern of inheritance, and all first-degree
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.